AI assistant
CYTOKINETICS INC — Director's Dealing 2013
May 29, 2013
30870_dirs_2013-05-29_61419618-b0ab-4e56-9b12-505085074f87.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2013-05-22
Reporting Person: HENDERSON JOHN T (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-22 | Non-Qualified Stock Option (right to buy) | $1.13 | A | 25000 | Acquired | 2023-05-22 | Common Stock (25000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1500 | Direct |
| Common Stock | 500 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $0.6702 | 2023-01-02 | Common Stock (130558) | 130558 | Direct |
| Non-Qualified Stock Option (right to buy) | $0.91 | 2022-05-22 | Common Stock (25000) | 25000 | Direct |
| Non-Qualified Stock Option (right to buy) | $0.98 | 2022-01-03 | Common Stock (51020) | 51020 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.44 | 2021-05-18 | Common Stock (20000) | 20000 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.75 | 2019-04-01 | Common Stock (21428) | 21428 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.85 | 2019-05-21 | Common Stock (15000) | 15000 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.95 | 2019-02-19 | Common Stock (30000) | 30000 | Direct |
| Non-Qualified Stock Option (right to buy) | $2.16 | 2021-01-03 | Common Stock (23148) | 23148 | Direct |
| Non-Qualified Stock Option (right to buy) | $2.81 | 2020-05-20 | Common Stock (20000) | 20000 | Direct |
| Non-Qualified Stock Option (right to buy) | $3.11 | 2020-01-04 | Common Stock (16077) | 16077 | Direct |
Footnotes
F1: This option shall vest and become exercisable as to 25,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 22, 2014.
F2: This option shall vest and become exercisable as to 130,558 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2014.
F3: This option shall vest and become exercisable as to 25,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 22, 2013.
F4: This option shall vest and become exercisable as to 51,020 shares divided into equal monthly installments such that the option shall be 100% vested on January 3, 2013.
F5: This option shall vest and become exercisable as to 20,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 18, 2012.
F6: This option shall vest and become exercisable as to 21,428 shares divided into equal monthly installments such that the option shall be 100% vested on January 1, 2010.
F7: This option shall vest and become exercisable as to 15,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 21, 2010.
F8: This option shall vest and become exercisable as to 833 shares on 03/19/09 and the balance of 29,167 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/19/12.
F9: This option shall vest and become exercisable as to 23,148 shares divided into equal monthly installments such that the option shall be 100% vested on January 3, 2012.
F10: This option shall vest and become exercisable as to 20,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 20, 2011.
F11: This option shall vest and become exercisable as to 16,077 shares divided into equal monthly installments such that the option shall be 100% vested on January 4, 2011.